Search Results - "Klyashtorny, V G"

Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure by Ignatieva, V. I., Kontsevaya, A. V., Lukyanov, M. M., Klyashtorny, V. G., Drapkina, O. M.

“…Aim. To make a cost-effectiveness analysis of increasing the prescription rate of combination therapy with beta-blockers (BBs), angiotensin-converting enzyme…”
Get full text

Biological vascular age and its relationship with cardiovascular risk factors by Akopyan, A. A., Strazhesko, I. D., Klyashtorny, V. G., Orlova, I. A.

“…Aim. To study of the relationship between cardiovascular risk factors and biological vascular age. Material and methods . The biological vascular age was…”
Get full text

Outpatient-Polyclinic Register of the Multidisciplinary Medical Center (TERRA): general characteristics and first results by Lukyanov, M. M., Andreenko, E. Yu, Smirnov, A. A., Kudryavtseva, M. M., Kuzina, N. N., Klyashtorny, V. G., Shepel, R. N., Ryzhakova, L. N., Drapkina, O. M.

“…Aim. To describe the experience of creating the Outpatient-Polyclinic Register of the Multi-specialty Medical Center (TERRA) and the first results of the…”
Get full text

Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Andreenko, E. Yu, Martsevich, S. Yu, Kutishenko, N. P., Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Pulin, A. A., Smirnov, А. А., Klyashtorny, V. G., Karpov, O. E., Drapkina, O. M.

“…Aim . To evaluate 24-month outcomes after hospital treatment of patients with coronavirus disease 2019 (COVID-19) in a prospective registry. Material and…”
Get full text

Outpatient register of patients who have suffered a myocardial infarction (REGATA): prospective follow-up data and outcomes by Pereverzeva, K G, Lukyanov, M M, Andreenko, E Yu, Klyashtorny, V G, Pravkina, E A, Drapkina, O M, Yakushin, S S

“…Aim      To determine the factors that influence the long-term prognosis in patients after myocardial infarction (MI) as a part of the prospective REGistry of…”
Get more information

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization by Mareev, Yu. V., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Smirnov, A. A., Kudryavtseva, M. M., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for…”
Get full text

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 by Kutishenko, N. P., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, А. А., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus…”
Get full text

Artificial intelligence in lung cancer screening: assessment of the diagnostic accuracy of the algorithm analyzing low-dose computed tomography by Morozov, S. P., Vladzimirskiy, A. V., Gombolevskiy, V. A., Klyashtorny, V. G., Fedulova, I. A., Vlasenkov, L. A.

“…The diagnostic accuracy of the artificial intelligence algorithm aimed to detect lesions on low-dose computer tomograms has been independently assessed. The…”
Get full text

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Kutishenko, N. P., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Sgibneva, A. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim . To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective…”
Get full text

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry by Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelny, A. V., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Sgibneva, А. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. According to hospital-based registry, to evaluate the age characteristics and prevalence of concomitant cardiovascular and non-сardiovascular diseases in…”
Get full text

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries) by Andreenko, E. Yu, Lukyanov, M. M., Yakushin, S. S., Makoveeva, A. N., Vorobiev, A. N., Pereverzeva, K. G., Kudryashov, E. V., Klyashtorny, V. G., Dindikova, V. A., Smirnov, A. A., Boytsov, S. A., Drapkina, O. M.

“…Aim. To assess the age and sex characteristics, comorbidities and medication therapy in patients with early cardiovascular multimorbidity in out- and…”
Get full text

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register) by Andreenko, E. Yu, Lukyanov, M. M., Yakushin, S. S., Vorobyev, A. N., Kudryashov, E. V., Yavelov, I. S., Klyashtorny, V. G., Pereverzeva, K. G., Boytsov, S. A., Drapkina, O. M.

“…Aim. To assess age and gender characteristics and determine comorbidity, medication, and outcomes in young ambulatory patients with cardiovascular diseases…”
Get full text

Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes by Drapkina, O. M., Karpov, O. E., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Akimkin, V. G., Andrenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelny, A. V., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Kudryashov, E. V., Klyashtorny, V. G., Smirnov, A. A., Fomina, V. S.

“…Aim. To characterize patients admitted to hospital with suspected or documented COVID-19 infection and community-acquired pneumonia (CAP) and to assess the…”
Get full text

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) by Loukianov, M. M., Andreenko, E. Yu, Martsevich, S. Yu, Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Okshina, E. Yu, Yakusevich, V. V., Yakusevich, V. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Klyashtorny, V. G., Kudryashov, E. V., Tatsii, Ju. E., Boytsov, S. A., Drapkina, O. M.

“…Aim . To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries…”
Get full text

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries) by Loukianov, M. M., Martsevich, S. Yu, Andrenko, E. Yu, Yakushin, S. S., Vorobiev, A. N., Pereverzeva, K. G., Zagrebelny, A. V., Okshina, Е. Yu, Yakusevich, V. V., Yakusevich, Vl. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. M., Mikhin, V. P., Maslennikova, Yu. V., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Makoveeva, A. N., Tatsii, Ju. E., Boytsov, S. A., Drapkina, O. M.

“…Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant…”
Get full text

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) by Loukianov, M. M., Martsevich, S. Yu, Drapkina, O. M., Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Yakusevich, V. Val, Yakusevich, V. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N, Mikhin, V. P., Maslennikova, Yu. V., Andreenko, E. Y., Klyashtorny, V. G., Kudryashov, E. V., Okshina, E. Yu, Panagopulu, M. A., Boytsov, S. A.

“…Aim.  To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled…”
Get full text

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes by Loukianov, M. M., Martsevich, S. Yu, Mareev, Yu. V., Yakushin, S. S., Andreenko, E. Yu, Vorobiev, A. N., Pereverzeva, K. G., Zagrebelny, A. V., Okshina, E. Yu, Yakusevich, V. V., Yakusevich, Vl. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Makoveeva, A. N., Tatsiy, Yu. E., Boytsov, S. A., Drapkina, O. M.

“…Aim . To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial…”
Get full text

Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident by Loukianov, M. M., Yakushin, S. S., Martsevich, S. Yu, Vorobyev, A. N., Pereverzeva, K. G., Okshina, E. Yu, Zagrebelnyy, A. V., Klyashtorny, V. G., Kudryashov, E. V., Boytsov, S. A., Drapkina, O. M.

“…Aim. To estimate outcomes and risk of all-cause mortality, cardiovascular (CV) mortality, and non-fatal CV events in patients with a history of acute…”
Get full text

Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION by Loukianov, M. M., Yakushin, S. S., Martsevich, S. Yu, Drapkina, O. M., Vorobyev, A. N., Zagrebelnyy, A. V., Kozminsky, A. N., Moseichuk, K. A., Pereverzeva, K. G., Pravkina, E. A., Okshina, E. Yu, Kudryashov, E. V., Belova, E. N., Klyashtorny, V. G., Boytsov, S. A.

“…Aim. To evaluate the structure of combined cardiovascular diseases, drug treatment and observation of patients with a history of stroke in the framework of…”
Get full text

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES by Loukianov, M. M., Martsevich, S. Yu, Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Yakusevich, V. Val, Yakusevich, V. Vl, Gomova, T. A., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Bichurina, M. A., Matskevich, L. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Deev, A. D., Drapkina, O. M., Boytsov, S. A.

“…Am. To study in the RECVASA registers the availability of data about the international normalized ratio (INR) indicator and achievement of its target values in…”
Get full text